SEER

Seer, Inc. Class A Common Stock

1.71

USD

SEER Earnings Reports

Positive Surprise Ratio

SEER beat 14 of 21 last estimates.

67%

Next Report

Date of Next Report

May 11, 2026

Estimate for Q1 26 (Revenue/ EPS)

$3.47M

-$0.28

Implied change from Q4 25 (Revenue/ EPS)

-17.45%

Implied change from Q1 25 (Revenue/ EPS)

-17.53%

-9.68%

Seer, Inc. Class A Common Stock earnings per share and revenue

On Feb 26, 2026, SEER reported earnings of -0.28 USD per share (EPS) for Q4 25, beating the estimate of -0.32 USD, resulting in a 11.15% surprise. Revenue reached 4.20 million, compared to an expected 4.69 million, with a -10.46% difference. The market reacted with a -17.31% price change (close before vs. close after earnings).

Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.28 USD, with revenue projected to reach 3.47 million USD, implying an increase of 0.00% EPS, and decrease of -17.45% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Precigen, Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.01

Surprise

+88.24%

Absci Corporation Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.19

Actual

-$0.23

Surprise

-16.04%

Candel Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.25

Actual

-$0.54

Surprise

-115.31%

LENZ Therapeutics, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.99

Actual

-$1.15

Surprise

-17.10%

Fennec Pharmaceuticals Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

$0.03

Actual

-$0.11

Surprise

-408.12%

Equillium, Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.06

Actual

-$0.04

Surprise

+35.28%

MaxCyte, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.06

Surprise

+26.47%

Celcuity Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$1.06

Actual

-$0.97

Surprise

+8.72%

TELA Bio, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.18

Actual

-$0.16

Surprise

+14.12%

Dyadic International, Inc.

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.04

Actual

-$0.06

Surprise

-30.72%

FAQ

What were Seer, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Seer, Inc. Class A Common Stock reported EPS of -$0.28, beating estimates by 11.15%, and revenue of $4.20M, -10.46% below expectations.

How did the market react to Seer, Inc. Class A Common Stock's Q4 2025 earnings?

The stock price moved down -17.31%, changed from $2.08 before the earnings release to $1.72 the day after.

When is Seer, Inc. Class A Common Stock expected to report next?

The next earning report is scheduled for May 11, 2026.

What are the forecasts for Seer, Inc. Class A Common Stock's next earnings report?

Based on 3 analysts, Seer, Inc. Class A Common Stock is expected to report EPS of -$0.28 and revenue of $3.47M for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.